Characterization of MHC Class I and Class II Immunopeptides in Lung Cancer From Needle-sized Biopsies Using an Optimized High-throughput Workflow - Biognosys

Characterization of MHC Class I and Class II Immunopeptides in Lung Cancer From Needle-sized Biopsies Using an Optimized High-throughput Workflow

Poster presented at ASBMB 2022

 
Presenter: Nigel Beaton
Sunday, August 14

Back to Resources overview

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Contact

    Close banner

    SpectroDive™ 11

    Straightforward Validation
    of Your Protein Targets

    New: SpectroDive™ 11

    Straightforward Validation of Your Protein Targets

    learn more